This comprehensive review explores the advancements and potential of Alzheimer's disease (AD) biomarkers in Asia, emphasizing their relevance to other cognitive disorders and various ethnicities.
It highlights the emerging role of AI-assisted retinal imaging and preliminary results from plasma biomarker screenings. While PET and CSF remain gold standards, the review integrates perspectives on blood-based biomarkers and innovative imaging techniques, including MRI and AI applications.